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In the recent paper by Aghabikoolei et al. [1], the authors
postulate that oral naltrexone prevents delayed respiratory
depression following naloxone reversal of methadone toxicity. We would like to voice a few concerns regarding the study.
The restriction of the study to only opiate naı̈ve patients
limits its applicability. Methadone is more frequently used
for the prevention of opioid withdrawal symptoms, for the
maintenance of opioid abstinence, or for the treatment of
chronic pain. Inherently, by the nature of access to the
medication, most people who are exposed are tolerant. It
seems problematic to include patients based on self- or
familial account that they do not use opiates. The number
of patients originally enrolled but subsequently excluded for
withdrawal symptoms after naloxone administration highlights the challenges of this approach.
Additionally, the half-life of methadone is approximately
48 hours and the 50 mg of naltrexone is expected to block the
effects of the methadone at the opioid receptors for approximately 24 hours. Since the patients in the naltrexone group
only had a mean hospital stay of 26 hours, many of them
left when they were still potentially vulnerable to delayed
respiratory depression. It would be important to know if any
returned for readmission or were subsequently found dead.
Abrupt and prolonged iatrogenic opioid withdrawal can
be severe and life threatening [2] and should be avoided.
This must be balanced by the need for ICU level care when

respiratory depression is predicted. As such, the results of
this study seem most applicable in unintentional ingestions in
children since they are usually opiate naı̈ve and often require
transfer for PICU level care.
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